Bacterial Consortium Therapy for Prevention of Recurrent C diff Infection, 4-Factor Prothrombin Complex Concentrate in Patients With Trauma, Review of Pituitary Adenomas, and more
JAMA Editors' Summary
00:00
Introduction
Kirsten Bippens-Domingo: JAMA Editor's Summary is a review of important research and review articles appearing in the latest JAMA issue. In this edition, we'll look at three original research reports on c-diffecile infection therapy called VE303. The second report examines the efficacy and safety of early administration of four-factor pro-thrombin complex (4F PCC) to patients with trauma at risk of massive transfusion.
Transcript
Play full episode
